Vident Investment Advisory, LLC Cellectis S.A. Transaction History

Vident Investment Advisory, LLC

$0
Q3 2023

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.39 - $4.93 $42,293 - $87,241	-17,696 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.45 - $8.77 $13,223 - $33,615	-3,833 Reduced 17.8%	17,696 $80,000
Q4 2021 Feb 14, 2022	BUY	$8.01 - $12.84 $172,447 - $276,432	21,529 New	21,529 $175,000
Q3 2021 Nov 12, 2021	SELL	$11.94 - $16.09 $170,359 - $229,572	-14,268 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$14.36 - $20.93 $204,888 - $298,629	14,268 New	14,268 $221,000
Q4 2020 Feb 08, 2021	SELL	$15.87 - $31.64 $1.26 Million - $2.51 Million	-79,271 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$15.7 - $20.84 $81,326 - $107,951	-5,180 Reduced 6.13%	79,271 $1.47 Million
Q2 2020 Jul 17, 2020	SELL	$8.21 - $21.02 $56,320 - $144,197	-6,860 Reduced 7.51%	84,451 $1.5 Million
Q1 2020 May 12, 2020	SELL	$7.81 - $18.82 $42,533 - $102,493	-5,446 Reduced 5.63%	91,311 $840,000
Q4 2019 Feb 11, 2020	BUY	$9.73 - $19.31 $66,095 - $131,172	6,793 Added 7.55%	96,757 $1.66 Million
Q3 2019 Nov 13, 2019	SELL	$10.15 - $16.89 $26,085 - $43,407	-2,570 Reduced 2.78%	89,964 $936,000
Q2 2019 Aug 12, 2019	BUY	$14.6 - $20.6 $159,621 - $225,219	10,933 Added 13.4%	92,534 $1.44 Million
Q1 2019 May 08, 2019	SELL	$15.53 - $19.75 $33,342 - $42,403	-2,147 Reduced 2.56%	81,601 $1.5 Million
Q4 2018 Feb 14, 2019	BUY	$15.58 - $28.41 $128,566 - $234,439	8,252 Added 10.93%	83,748 $1.39 Million
Q3 2018 Nov 14, 2018	SELL	$25.99 - $30.6 $130,755 - $153,948	-5,031 Reduced 6.25%	75,496 $2.13 Million
Q2 2018 Aug 14, 2018	BUY	$27.78 - $38.53 $520,319 - $721,666	18,730 Added 30.31%	80,527 $2.28 Million
Q1 2018 May 14, 2018	BUY	$27.78 - $35.19 $466,370 - $590,769	16,788 Added 37.3%	61,797 $1.89 Million
Q4 2017 Feb 15, 2018	SELL	$23.33 - $35.01 $152,414 - $228,720	-6,533 Reduced 12.68%	45,009 $1.31 Million
Q3 2017 Nov 14, 2017	BUY	$21.65 - $32.18 $1.12 Million - $1.66 Million	51,542	51,542 $1.47 Million

Others Institutions Holding CLLS

# of Institutions

Shares Held

10.8M

Call Options Held

5.9K

Put Options Held

1.4K

Long Focus Capital Management, LLC San Juan, PR

4.62M
Shares

$7.2 Million
0.36% of portfolio
Capital International Investors Los Angeles, CA

1.85M
Shares

$2.88 Million
0.0% of portfolio
Credit Suisse Ag Zurich, V8

1.44M
Shares

$2.24 Million
0.0% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

1.44M
Shares

$2.24 Million
0.0% of portfolio
Baillie Gifford & CO

694K
Shares

$1.08 Million
0.0% of portfolio

View Full List

About Cellectis S.A.

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $71M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

More about CLLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Account